Literature DB >> 14577578

Identification of a new missense mutation in the mtDNA of hereditary hypertrophic, but not dilated cardiomyopathic hamsters.

Marilena Minieri1, Mara Zingarelli, Huda Shubeita, Alba Vecchini, Luciano Binaglia, Felicia Carotenuto, Cristina Fantini, Roberta Fiaccavento, Laura Masuelli, Anna Coletti, Lucilla Simonelli, Andrea Modesti, Paolo Di Nardo.   

Abstract

The cardiomyopathic hamster is characterized by a naturally occurring deletion in the delta-sarcoglycan gene generating either the hypertrophic or the dilatative phenotype of cardiomyopathy. This evidence suggests that other genetic or environmental factors might concur to the pathogenesis of cardiomyopathy. The aim of the present study was to investigate on the possibility that other genes are involved in the pathogenesis of hamster cardiomyopathy. For this purpose, a series of genes of cardiomyopathic and healthy hamsters were compared by the differential display technique. The hamster cytochrome c oxidase mitochondrial subunit III (COIII) gene has been sequenced and identified as the gene upregulated in brain and skeletal muscle. The gene sequencing and restriction analysis demonstrated that a missense mutation is present in the COIII gene of hamsters exhibiting hypertrophic cardiomyopathy while no mutations were present in dilatative cardiomyopathic hamsters. The mutation was heteroplasmic and the heteroplasmy level was increased with age in skeletal muscle and heart. The ultrastructural analysis of cardiac tissue showed severe damage in the mitochondrial structure of hypertrophic but not dilatative hamster hearts. These results suggest that the pathogenesis of the cardiac damage in hypertrophic cardiomyopathic hamster may be sustained by multiple mutations exerting a cumulative effect on both structure and function of cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577578     DOI: 10.1023/a:1025542731335

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

Review 1.  Recent advances in the molecular genetics of hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

2.  Biochemical aspects of muscle necrosis in hamster dystrophy.

Authors:  K Wrogemann; W A Hayward; M C Blanchaer
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 3.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

4.  Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.

Authors:  A Sakamoto; K Ono; M Abe; G Jasmin; T Eki; Y Murakami; T Masaki; T Toyo-oka; F Hanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.

Authors:  E Arbustini; R Fasani; P Morbini; M Diegoli; M Grasso; B Dal Bello; E Marangoni; P Banfi; N Banchieri; O Bellini; G Comi; J Narula; C Campana; A Gavazzi; C Danesino; M Viganò
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 6.  Molecular genetics of familial hypertrophic cardiomyopathy.

Authors:  C Hengstenberg; K Schwartz
Journal:  J Mol Cell Cardiol       Date:  1994-01       Impact factor: 5.000

7.  The cytochrome c oxidase of Paracoccus denitrificans pumps protons in a reconstituted system.

Authors:  M Solioz; E Carafoli; B Ludwig
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

8.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A.

Authors:  T Tsukihara; H Aoyama; E Yamashita; T Tomizaki; H Yamaguchi; K Shinzawa-Itoh; R Nakashima; R Yaono; S Yoshikawa
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

10.  Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

Authors:  R Coral-Vazquez; R D Cohn; S A Moore; J A Hill; R M Weiss; R L Davisson; V Straub; R Barresi; D Bansal; R F Hrstka; R Williamson; K P Campbell
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

View more
  3 in total

1.  Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters.

Authors:  Roberta Fiaccavento; Felicia Carotenuto; Marilena Minieri; Laura Masuelli; Alba Vecchini; Roberto Bei; Andrea Modesti; Luciano Binaglia; Angelo Fusco; Aldo Bertoli; Giancarlo Forte; Luciana Carosella; Paolo Di Nardo
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Authors:  Comlan Missihoun; David Zisa; Arsalan Shabbir; Huey Lin; Techung Lee
Journal:  Mol Cell Biochem       Date:  2008-08-26       Impact factor: 3.396

3.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.